MAO Inhibitors
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Antidepressants are among the most commonly prescribed medications in primary care, yet a new antidepressant which became available over a year ago has not been widely used. Dr. Paul Markowitz discusses MAO inhibitors and dispels many of the myths surrounding using them.
Overview
Antidepressants are among the most commonly prescribed medications in primary care, yet a new antidepressant which became available over a year ago has not been widely used. Dr. Paul Markowitz discusses MAO inhibitors and dispels many of the myths surrounding using them.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Phase 3 study results of plozasiran in patients with FCS
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
Level Up Your Skills: Tailoring Management of HF
FINE-HEART Pooled Analysis
NYHA FC and Finerenone Response: Clinical Trial Insights
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?